Effects of pentoxifylline on inflammatory cytokine expression and acute pleuropneumonia in Swine

Immunobiology

Volumn 205, Issue 1, 2002, Pages 17-34

  Myers, Michael J ^a   Baarsch, Mary J ^b   Murtaugh, Michael P ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BARBITURIC ACID DERIVATIVE; CONCANAVALIN A; CYTOKINE; DEXTRAN; ENDOTOXIN; FORMAZAN; HAPTOGLOBIN; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; IRON; KETAMINE; MESSENGER RNA; METHYLXANTHINE DERIVATIVE; MITOCHONDRIAL ENZYME; N,N DIMETHYLFORMAMIDE; PENTOXIFYLLINE; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IV INHIBITOR; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 6; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; XYLAZINE; ZINC;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL PNEUMONIA; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIARRHEA; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; ESCHERICHIA COLI; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TREMOR; VOMITING;

EID: 0036208592     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00108     Document Type: Article

References (47)

1. Actinobacillus pleuropneumoniae
2. Actinobacillus (Haemophilus) pleuropneumoniae. Part I. History, epidemiology, serotyping, and treatment
3. The proper use and benefits of veterinary antimicrobial agents in swine practice
4. Pulmonary lesions in mice inoculated with Actinobacillus pleuropneumoniae hemolysin and lipopolysaccharide
5. Role of Haemophilus pleuropneumoniae lipopolysaccharide endotoxin in the pathogenesis of porcine Haemophilus pleuropneumonia
6. Inflammatory cytokines in animal health and disease
7. Inflammatory cytokine expression in swine experimentally infected with Actinobacillus pleuropneumoniae
8. Pathophysiological correlates of acute porcine pleuropneumonia
9. Interleukin-10 gene therapy-mediated amelioration of bacterial pneumonia
10. Group B Streptococcus induces tumor necrosis factor in neonatal pigs. Effect of the tumor necrosis factor inhibitor pentoxifylline on hemodynamics and gas exchange
11. Early post-treatment with pentoxifylline or dibutyryl cAMP attenuates Escherichia coli-induced acute lung injury in guinea pigs
12. Pharmacology of pentoxifylline, a hemorrheologic agent for the treatment of intermittent claudication
13. ARDS, neutrophils, and pentoxifylline
14. Attenuation of acute lung injury in septic guinea pigs with pentoxifylline
15. Increase of survival rate by pentoxifylline in endotoxic shock
16. Effects of pentoxifylline on phagocyte responses in vitro and acute and chronic inflammation reactions in vivo
17. Attenuation of tumor necrosis factor-induced endothelial cell cytotoxicity and neutrophil chemiluminescence
18. Pentoxifylline in endotoxaemia
19. Effect of dexamethasone or HWA-138 in combination with antibiotics in experimental Haemophilus influenzae type b infection
20. Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1 beta
21. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
22. Study of the solid phase extraction of pentoxifylline and its major metabolite as a basis of their rapid low concentration gas chromatographic determination in serum
23. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy
24. Acute phase responses after acute liver injury by partial hepatectomy in rats as indicators of cytokine release
25. Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-α and interleukin-1β by human mononuclear cells
26. Pentoxifylline suppression of tumor necrosis factor gene transcription
27. Inhibition of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) messenger RNA (mRNA) expression in HL-60 leukemia cells by pentoxifylline and dexamethasone: Dissociation of acivicin-induced TNF-α expression from acivicin-induced monocytoid differentiation
28. Pentoxifylline does not attenuate acute lung injury in the absence of granulocytes
29. The effects of pentoxifylline on lipopolysaccharide (LPS) fever, plasma interleukin 6 (IL-6), and tumor necrosis factor (TNF) in the rat
30. Group B streptococcal sepsis in piglets: Effect of combined pentoxifylline and indomethacin pretreatment
31. Effect of pentoxifylline on cytokine- and eicosanoid-induced acute pulmonary hypertension in piglets
32. Differential effects of pentoxifylline, a non-specific phosphodiesterase inhibitor, on the production of IL-10, IL-12 p40 and p35 subunits by murine peritoneal macrophages
33. The efficacy of pentoxifylline as an anti-inflammatory agent in experimental Escherichia coli meningitis in the newborn piglet
34. Increasing doses of pentoxifylline as a continuous infusion in canine septic shock
35. Long-term pretreatment with pentoxifylline increases random skin flap survival
36. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: Extrapolation of data to benzodiazepines and phenytoin
37. Identification of multiple constitutive and inducible cytochrome P450 enzymes in market weight swine
38. Kinetics of intravenous and oral pentoxifylline in healthy subjects
39. Pharmacokinetics of orally administered pentoxifylline in humans
40. Pharmacokinetics of pentoxifylline and its metabolites in healthy mice and in mice infected with Candida albicans
41. Characterization of a high molecular weight tumor necrosis factor-α mRNA in influenza A virus-infected macrophages
42. Infection of macrophages by influenza A virus: Characterization of tumour necrosis factor-alpha (TNF-alpha) gene expression
43. Involvement of 26-kDa membrane-bound tumour necrosis factor precursor in bidirectional feedback regulation on 17-kDa tumour necrosis factor production after stimulation by lipopolysaccharide
44. Processing and release of tumor necrosis factor alpha
45. Noncleavable transmembrane mouse tumor necrosis factor-α (TNF-α) mediates effects distinct from those of wild-type TNF-α in vitro and in vivo